A detailed history of Marex Group PLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Marex Group PLC holds 53,533 shares of BHC stock, worth $336,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,533
Holding current value
$336,187
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$5.71 - $8.34 $305,673 - $446,465
53,533 New
53,533 $345,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.27B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Marex Group PLC Portfolio

Follow Marex Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marex Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Marex Group PLC with notifications on news.